Report cover image

Epigenetics Diagnostics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Publisher Persistence Research & Consultancy Services
Published Mar 03, 2026
Length 195 Pages
SKU # PERR20937403

Description

Persistence Market Research has recently released a comprehensive report on the global epigenetics diagnostics market. The report provides an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the expected growth trajectory of the global epigenetics diagnostics market from 2025 to 2032.

Key Insights: Epigenetics Diagnostics Market
  • Market Size (2025E): US$ 19.27 Bn
  • Projected Market Value (2032F): US$ 53.78 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 15.8%
Epigenetics Diagnostics Market – Report Scope:

Epigenetics diagnostics encompass tools, reagents, kits, instruments, enzymes, and services used to detect epigenetic modifications such as DNA methylation, histone modifications, and chromatin remodeling. These diagnostics are widely applied in oncology and non-oncology areas to aid in early disease detection, personalized medicine, and monitoring therapeutic responses. The market caters to research institutions, hospitals, diagnostic laboratories, and biotech companies. Growth is driven by increasing prevalence of cancer and other chronic diseases, rising adoption of precision medicine, and technological advancements in high-throughput epigenetic analysis platforms.

Market Growth Drivers:

The global epigenetics diagnostics market is fueled by the growing demand for personalized medicine and early disease detection solutions. Advancements in molecular diagnostics technologies, including next-generation sequencing (NGS) and microarrays, enable accurate and rapid epigenetic profiling. The increasing incidence of oncology-related disorders and the need for biomarkers to guide targeted therapies further drive market expansion. Moreover, rising investment in genomics and epigenomics research, coupled with collaborations between diagnostic companies and academic institutions, supports market growth.

Market Restraints:

Despite promising growth prospects, the epigenetics diagnostics market faces challenges related to high costs of advanced diagnostic instruments and reagents, which may limit adoption in price-sensitive regions. Regulatory complexities and stringent validation requirements for clinical applications can delay product approvals and commercialization. Limited awareness about epigenetic diagnostics among healthcare providers in certain regions also poses a barrier to market penetration.

Market Opportunities:

The market presents significant opportunities through the development of innovative, high-throughput, and cost-effective epigenetic diagnostic platforms. Expansion into emerging economies with growing healthcare infrastructure and rising disease burden offers untapped potential. Increasing focus on oncology applications, including early detection and companion diagnostics, and the growing integration of artificial intelligence and machine learning in epigenetics data analysis are expected to further accelerate market adoption.

Key Questions Answered in the Report:
  • What are the primary factors driving the growth of the epigenetics diagnostics market globally?
  • Which product types and technologies are witnessing the highest adoption?
  • How are technological advancements reshaping the competitive landscape of the market?
  • Who are the key players contributing to the epigenetics diagnostics market, and what strategies are they employing?
  • What are the emerging trends and future growth prospects in the global market?
Competitive Intelligence and Business Strategy:

Leading players in the global epigenetics diagnostics market focus on product innovation, strategic partnerships, and expansion into emerging markets to maintain competitiveness. Companies invest in research and development to improve assay sensitivity, throughput, and reproducibility. Collaborations with hospitals, research institutes, and biotech companies help expand product portfolios and enhance market reach. Additionally, investments in automation, bioinformatics, and AI-based analytics support efficient and accurate epigenetic profiling, fostering market growth.

Key Companies Profiled:
  • Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Eisai Co. Ltd.
  • Novartis AG
  • Element Biosciences, Inc.
  • Cantata Bio (Dovetail Genomics LLC.)
  • Illumina, Inc.
  • ValiRx Plc.
  • Abcam Ltd.
Epigenetics Diagnostics Market Research Segmentation:

By Product:
  • Reagents
  • Kits
  • Instruments
  • Enzymes
  • Services
By Technology:
  • Histone Methylation
  • Others
By Application:
  • Oncology
  • Non-oncology
By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

195 Pages
1. Executive Summary
1.1. Epigenetics Diagnostics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Pipeline Analysis
3.3. Product Adoption Analysis
3.4. Value Chain Analysis
3.5. Key Promotional Strategies by Manufacturers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Epigenetics Diagnostics Market Outlook:
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Epigenetics Diagnostics Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
4.3.3.1. Reagents
4.3.3.2. Kits
4.3.3.3. Instruments
4.3.3.4. Enzymes
4.3.3.5. Services
4.3.4. Market Attractiveness Analysis: Product
4.4. Global Epigenetics Diagnostics Market Outlook: Technology
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, Technology, 2019-2024
4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
4.4.3.1. DNA Methylation
4.4.3.2. Histone Methylation
4.4.3.3. Histone Acetylation
4.4.3.4. Large Non - Coding RNA
4.4.3.5. MicroRNA Modification
4.4.3.6. Chromatin Structures
4.4.4. Market Attractiveness Analysis: Technology
4.5. Global Epigenetics Diagnostics Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
4.5.3.1. Oncology
4.5.3.2. Non-oncology
4.5.4. Market Attractiveness Analysis: Application
5. Global Epigenetics Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Epigenetics Diagnostics Market Outlook:
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
6.4.1. Reagents
6.4.2. Kits
6.4.3. Instruments
6.4.4. Enzymes
6.4.5. Services
6.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
6.5.1. DNA Methylation
6.5.2. Histone Methylation
6.5.3. Histone Acetylation
6.5.4. Large Non - Coding RNA
6.5.5. MicroRNA Modification
6.5.6. Chromatin Structures
6.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
6.6.1. Oncology
6.6.2. Non-oncology
6.7. Market Attractiveness Analysis
7. Europe Epigenetics Diagnostics Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Technology
7.2.4. By Application
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
7.4.1. Reagents
7.4.2. Kits
7.4.3. Instruments
7.4.4. Enzymes
7.4.5. Services
7.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
7.5.1. DNA Methylation
7.5.2. Histone Methylation
7.5.3. Histone Acetylation
7.5.4. Large Non - Coding RNA
7.5.5. MicroRNA Modification
7.5.6. Chromatin Structures
7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
7.6.1. Oncology
7.6.2. Non-oncology
7.7. Market Attractiveness Analysis
8. East Asia Epigenetics Diagnostics Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Technology
8.2.4. By Application
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
8.4.1. Reagents
8.4.2. Kits
8.4.3. Instruments
8.4.4. Enzymes
8.4.5. Services
8.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
8.5.1. DNA Methylation
8.5.2. Histone Methylation
8.5.3. Histone Acetylation
8.5.4. Large Non - Coding RNA
8.5.5. MicroRNA Modification
8.5.6. Chromatin Structures
8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
8.6.1. Oncology
8.6.2. Non-oncology
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Epigenetics Diagnostics Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Technology
9.2.4. By Application
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
9.4.1. Reagents
9.4.2. Kits
9.4.3. Instruments
9.4.4. Enzymes
9.4.5. Services
9.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
9.5.1. DNA Methylation
9.5.2. Histone Methylation
9.5.3. Histone Acetylation
9.5.4. Large Non - Coding RNA
9.5.5. MicroRNA Modification
9.5.6. Chromatin Structures
9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
9.6.1. Oncology
9.6.2. Non-oncology
9.7. Market Attractiveness Analysis
10. Latin America Epigenetics Diagnostics Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Technology
10.2.4. By Application
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
10.4.1. Reagents
10.4.2. Kits
10.4.3. Instruments
10.4.4. Enzymes
10.4.5. Services
10.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
10.5.1. DNA Methylation
10.5.2. Histone Methylation
10.5.3. Histone Acetylation
10.5.4. Large Non - Coding RNA
10.5.5. MicroRNA Modification
10.5.6. Chromatin Structures
10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
10.6.1. Oncology
10.6.2. Non-oncology
10.7. Market Attractiveness Analysis
11. Middle East & Africa Epigenetics Diagnostics Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Technology
11.2.4. By Application
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
11.4.1. Reagents
11.4.2. Kits
11.4.3. Instruments
11.4.4. Enzymes
11.4.5. Services
11.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
11.5.1. DNA Methylation
11.5.2. Histone Methylation
11.5.3. Histone Acetylation
11.5.4. Large Non - Coding RNA
11.5.5. MicroRNA Modification
11.5.6. Chromatin Structures
11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
11.6.1. Oncology
11.6.2. Non-oncology
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Abcam Ltd.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Hoffmann- La Roche Ltd.
12.3.3. Thermo Fisher Scientific, Inc.
12.3.4. Eisai Co. Ltd.
12.3.5. Novartis AG
12.3.6. Element Biosciences, Inc.
12.3.7. Cantata Bio (Dovetail Genomics LLC)
12.3.8. Illumina, Inc.
12.3.9. ValiRx Plc.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us